Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by combining ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Ascentage Pharma is discovering and developing small molecule drugs for the treatment of cancer that block or degrade protein targets implicated in cancer. It has active clinical programs targeting ...